HUAKANG PHARMACEUTICAL
HUAKANG PHARMACEUTICAL, headquartered in China, is a prominent player in the pharmaceutical industry, specialising in the research, development, and manufacturing of high-quality generic and innovative drugs. Founded in 2001, the company has established a strong presence in major operational regions across Asia and beyond, focusing on therapeutic areas such as oncology, cardiology, and neurology. With a commitment to excellence, HUAKANG PHARMACEUTICAL offers a diverse portfolio of products, including active pharmaceutical ingredients (APIs) and finished dosage forms. Their unique approach to quality assurance and regulatory compliance has positioned them as a trusted partner in the global market. Notable achievements include successful collaborations with international pharmaceutical companies, underscoring their reputation for reliability and innovation in the healthcare sector.
DitchCarbon Score
How does HUAKANG PHARMACEUTICAL's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HUAKANG PHARMACEUTICAL's score of 5 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
HUAKANG PHARMACEUTICAL's reported carbon emissions
In 2023, HUAKANG PHARMACEUTICAL reported total carbon emissions of approximately 132,470 kg CO2e. This figure includes Scope 1 emissions of about 17,330 kg CO2e, Scope 2 emissions of around 107,910 kg CO2e, and Scope 3 emissions totalling approximately 6,230 kg CO2e. Within Scope 3, significant contributors were business travel at about 4,030 kg CO2e and purchased goods and services at approximately 1,060 kg CO2e. Despite the detailed emissions reporting, HUAKANG PHARMACEUTICAL has not set specific reduction targets or climate pledges. The company has disclosed its emissions across all relevant scopes, indicating a commitment to transparency in its environmental impact. However, without defined reduction initiatives or targets, the company's long-term climate strategy remains unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2023 | |
|---|---|
| Scope 1 | 17,330 |
| Scope 2 | 107,910 |
| Scope 3 | 6,230 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
HUAKANG PHARMACEUTICAL is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
